CIAPIN1 Antibody

What is CIAPIN1 and why is it significant in research?

CIAPIN1 (also known as Anamorsin or DRE2) is a newly identified anti-apoptotic molecule that plays crucial roles in various cellular processes. It functions as a mediator of RAS signaling pathways and is essential for fetal liver hematopoiesis . CIAPIN1 has gained significance in research due to its involvement in multiple cancer types, including breast, gastric, colorectal, and esophageal cancers . Its role in regulating apoptosis, cell proliferation, and drug resistance makes it a valuable target for understanding disease mechanisms and potential therapeutic development.

What is the subcellular localization of CIAPIN1 and how does this impact antibody selection?

CIAPIN1 exhibits a complex subcellular distribution pattern, being localized in both the cytoplasm and nucleus, with particular accumulation in the nucleolus . Bioinformatic prediction has identified a putative nuclear localization signal and nuclear export signal within both human and mouse CIAPIN1, suggesting it undergoes cytoplasm-nucleus-nucleolus translocation . When selecting antibodies, researchers should consider those validated for detecting CIAPIN1 in multiple cellular compartments, particularly if studying its translocation or compartment-specific functions. Antibodies with demonstrated reactivity in both native and denatured forms would be preferable for comprehensive analysis across different experimental techniques .

What species reactivity should be considered when selecting a CIAPIN1 antibody?

Most commercially available CIAPIN1 antibodies demonstrate reactivity with human samples, while some also cross-react with mouse CIAPIN1 . When working with animal models, it's essential to verify species cross-reactivity. For example, the polyclonal antibody listed as ABIN7307660 shows reactivity to both human and mouse CIAPIN1 , while some monoclonal antibodies may be human-specific . Researchers should carefully check the product documentation for validated species reactivity and consider confirming cross-reactivity through preliminary experiments if working with non-validated species.

How should samples be prepared for optimal CIAPIN1 detection in Western blotting?

For Western blotting applications, samples should be carefully prepared to preserve CIAPIN1 integrity. Based on multiple antibody specifications, CIAPIN1 is typically observed at approximately 34-37 kDa molecular weight . Sample preparation should include:

• Efficient cell lysis using buffers containing protease inhibitors

• SDS-PAGE separation (6% gels have been successfully used)

• Complete protein transfer to membranes (PVDF or nitrocellulose)

• Appropriate blocking to reduce background

• Primary antibody dilutions ranging from 1:500 to 1:2000 for polyclonal antibodies or approximately 1:600 for monoclonal antibodies

Include positive controls when possible, particularly when first optimizing the protocol, as CIAPIN1 expression levels vary across tissue types.

What are the recommended fixation and antigen retrieval methods for CIAPIN1 immunohistochemistry?

For immunohistochemical detection of CIAPIN1, formalin-fixed paraffin-embedded (FFPE) tissue samples have been successfully used . The optimal methodology includes:

• Standard tissue fixation in 10% neutral buffered formalin

• Paraffin embedding and sectioning (typically 4-5 μm thickness)

• Deparaffinization and rehydration

• Antigen retrieval (heat-induced epitope retrieval in citrate buffer pH 6.0 is commonly effective)

• Blocking of endogenous peroxidase activity

• Primary antibody incubation at dilutions of approximately 1:50 to 1:200

• Detection using appropriate secondary antibody systems

For immunofluorescence applications, similar fixation protocols can be employed, with antibody dilutions in the range of 1:50 to 1:200 .

How can I validate the specificity of a CIAPIN1 antibody for my research?

Validating antibody specificity is crucial for reliable research outcomes. For CIAPIN1 antibodies, consider these validation approaches:

• Positive and negative controls: Include tissues or cell lines known to express high levels (breast cancer tissues) and low levels of CIAPIN1 (some normal tissues)

• Knockdown/knockout validation: Compare staining between wild-type samples and those with CIAPIN1 knockdown or knockout

• Multiple antibody comparison: Use antibodies from different sources or with different epitopes

• Western blot confirmation: Verify a single band at the expected molecular weight (approximately 34-37 kDa)

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide to confirm specific binding

Research has shown CIAPIN1 expression varies significantly between cancer tissues and normal tissues, providing natural controls for validation .

What are the optimal conditions for using CIAPIN1 antibodies in immunofluorescence studies?

For immunofluorescence applications with CIAPIN1 antibodies, researchers should consider:

• Fixation: 4% paraformaldehyde is commonly effective

• Permeabilization: Moderate permeabilization (0.1-0.3% Triton X-100) is necessary to access both cytoplasmic and nuclear CIAPIN1

• Blocking: Use 5-10% normal serum from the secondary antibody host species

• Primary antibody dilution: 1:50 to 1:200 dilutions are typically effective

• Counterstaining: Include nuclear counterstains like DAPI to verify nuclear/nucleolar localization

• Microscopy settings: Use confocal microscopy when possible to clearly distinguish cytoplasmic, nuclear, and nucleolar localization

Research has shown that CIAPIN1 demonstrates strongest staining in the nucleolus, with diffuse staining throughout cytoplasm and nucleus, so appropriate exposure settings are critical .

How should CIAPIN1 antibodies be used for studying protein interactions through co-immunoprecipitation?

When designing co-immunoprecipitation experiments to study CIAPIN1 interactions:

• Lysis conditions: Use non-denaturing lysis buffers to preserve protein-protein interactions

• Antibody selection: Choose antibodies validated for immunoprecipitation applications

• Controls: Include IgG controls and input samples

• Elution conditions: Optimize to minimize antibody contamination in eluates

• Detection: Use reciprocal co-immunoprecipitation when possible to confirm interactions

When investigating CIAPIN1 interactions, consider its known roles in JAK2-STAT3 signaling pathways and PKM2 interactions , which may guide experimental design for interaction studies.

What considerations are important for quantitative analysis of CIAPIN1 expression in tissue microarrays?

For quantitative analysis of CIAPIN1 in tissue microarrays:

• Scoring systems: Establish clear criteria for intensity and percentage of positive cells

• Reference standards: Include control tissues with known CIAPIN1 expression levels

• Multiple observers: Have at least two independent observers score samples

• Subcellular localization: Document both cytoplasmic and nuclear staining separately

• Correlation analysis: Correlate CIAPIN1 expression with clinical parameters

Research has demonstrated that CIAPIN1 expression correlates with clinical features in breast cancer, including T stage, histological type, age, ER status, PR status, and PAM50 classification . This information can guide interpretation of tissue microarray results.

How can CIAPIN1 antibodies be used to investigate its role in cancer drug resistance mechanisms?

CIAPIN1 has been identified as a mediator of multidrug resistance (MDR) in gastric cancer cells . To investigate its role in drug resistance:

• Expression analysis: Compare CIAPIN1 levels in drug-sensitive and resistant cell lines using validated antibodies in Western blot or immunofluorescence

• Functional studies: Combine CIAPIN1 knockdown or overexpression with drug sensitivity assays

• Pathway analysis: Investigate correlations between CIAPIN1 expression and MDR-related proteins like MDR1 and MRP1

• Clinical correlation: Analyze CIAPIN1 expression in patient samples before and after treatment failure

Research has shown that CIAPIN1 expression is upregulated in MDR gastric cancer cell lines , providing a foundation for investigating its role in other cancer types.

What approaches can be used to study CIAPIN1's role in cellular stress responses using antibody-based methods?

To investigate CIAPIN1's function in cellular stress responses:

• Stress induction models: Apply various stressors (oxidative stress, hypoxia, nutrient deprivation) and monitor CIAPIN1 expression and localization changes

• Co-localization studies: Use dual immunofluorescence with stress-response proteins

• Phosphorylation analysis: Investigate post-translational modifications of CIAPIN1 under stress conditions

• Chromatin association: Perform ChIP assays if investigating CIAPIN1's nuclear functions

Research has shown that CIAPIN1 downregulation increases reactive oxygen species (ROS) production and oxidative stress in breast cancer cells , suggesting an important role in redox homeostasis that can be further investigated with appropriate antibody-based methods.

How can CIAPIN1 antibodies be used to investigate its role in the STAT3/PKM2 pathway in glycolysis regulation?

CIAPIN1 has been shown to regulate glycolysis in breast cancer cells through the STAT3/PKM2 pathway . To investigate this relationship:

• Co-immunoprecipitation: Study physical interactions between CIAPIN1, STAT3, and PKM2

• Phosphorylation analysis: Monitor STAT3 phosphorylation levels in relation to CIAPIN1 expression

• Nuclear translocation: Track STAT3 nuclear translocation using fractionation and immunofluorescence

• Metabolic assays: Correlate CIAPIN1 expression with glycolytic parameters including pyruvate, lactate, and ATP production

Research has demonstrated that CIAPIN1 inhibition suppresses pyruvate, lactate, and ATP production and reduces PKM2 protein expression and STAT3 phosphorylation in breast cancer cells , providing a foundation for further mechanistic studies.

What are common issues in CIAPIN1 Western blotting and how can they be resolved?

Common challenges in CIAPIN1 Western blotting include:

CIAPIN1 has an expected molecular weight of 34 kDa but is often observed at 37 kDa , possibly due to post-translational modifications. If seeing unexpected band patterns, verify with multiple antibodies targeting different epitopes.

How can non-specific staining be minimized in CIAPIN1 immunohistochemistry?

To reduce non-specific staining in CIAPIN1 immunohistochemistry:

• Optimize antibody dilution: Typically 1:50 to 1:200 for most CIAPIN1 antibodies

• Improve blocking: Use 5-10% normal serum from the secondary antibody host species

• Include absorption controls: Pre-incubate antibody with immunizing peptide

• Optimize antigen retrieval: Test multiple methods if background persists

• Reduce endogenous peroxidase activity: Thorough quenching before antibody incubation

• Consider tissue-specific autofluorescence: Use appropriate quenching methods for immunofluorescence

Compare staining patterns with published results showing CIAPIN1 localization in both cytoplasm and nucleus with nucleolar accumulation .

How should researchers interpret discrepancies in CIAPIN1 expression between different cancer types?

Research has shown variable CIAPIN1 expression across cancer types:

• Upregulated in: Breast cancer, gastric cancer, colorectal cancer, esophageal carcinoma, bladder urothelial carcinoma, endometrial carcinoma, and several others

• Downregulated in: Chromophobe, clear cell, and thyroid carcinomas

When interpreting discrepancies:

• Consider tissue-specific roles of CIAPIN1 in different cellular contexts

• Analyze correlation with other markers specific to each cancer type

• Examine relationships to prognosis and treatment response across cancer types

• Investigate possible isoforms or post-translational modifications that might differ between tissues

These varied expression patterns suggest context-dependent functions of CIAPIN1 that warrant tissue-specific investigation.

What are the implications of CIAPIN1's subcellular localization for functional studies?

CIAPIN1's complex localization pattern has important research implications:

• Dual localization: CIAPIN1 is found in both cytoplasm and nucleus, with accumulation in the nucleolus

• Translocation mechanisms: It contains putative nuclear localization and export signals

• Compartment-specific functions: Different roles may exist in different cellular compartments

When designing functional studies:

• Track localization changes in response to stimuli or stress conditions

• Consider separate analysis of cytoplasmic versus nuclear functions

• Investigate potential shuttle proteins or transport mechanisms

• Design compartment-specific knockdown or overexpression studies

The nucleolar accumulation is particularly intriguing and may suggest roles in ribosome biogenesis or other nucleolar functions that have not been fully characterized.

How can CIAPIN1 expression data be integrated with clinical parameters for prognostic studies?

CIAPIN1 expression has demonstrated prognostic value in multiple cancer types. For integrative analysis:

This information provides a framework for similar analyses in other cancer types and clinical contexts.